Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

First round brings in $37mm for Optherion

Executive Summary

Optherion (developing ophthalmic drug candidates and diagnostics) raised $37mm in its Series A financing from Quaker BioVentures, Domain Associates, Johnson & Johnson Development Corp., Purdue Pharma, Pappas Ventures, Biogen Idec New Ventures, and GE Healthcare Financing Services. A member from Quaker and Domain joined the company's board.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies